+

NL7306234A - - Google Patents

Info

Publication number
NL7306234A
NL7306234A NL7306234A NL7306234A NL7306234A NL 7306234 A NL7306234 A NL 7306234A NL 7306234 A NL7306234 A NL 7306234A NL 7306234 A NL7306234 A NL 7306234A NL 7306234 A NL7306234 A NL 7306234A
Authority
NL
Netherlands
Application number
NL7306234A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7306234A publication Critical patent/NL7306234A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
NL7306234A 1972-05-05 1973-05-04 NL7306234A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
NL7306234A true NL7306234A (xx) 1973-11-07

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7306234A NL7306234A (xx) 1972-05-05 1973-05-04

Country Status (16)

Country Link
JP (1) JPS4961150A (xx)
AT (1) AT355232B (xx)
AU (1) AU475168B2 (xx)
BE (1) BE799102A (xx)
CA (1) CA1013341A (xx)
CH (1) CH617710A5 (xx)
DE (1) DE2322532A1 (xx)
ES (1) ES414411A1 (xx)
FR (1) FR2183792B1 (xx)
GB (1) GB1430942A (xx)
IE (1) IE37596B1 (xx)
IL (1) IL42196A (xx)
LU (1) LU67546A1 (xx)
NL (1) NL7306234A (xx)
SE (1) SE400771B (xx)
ZA (1) ZA733035B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
WO1995021617A1 (en) * 1994-02-14 1995-08-17 Cocensys, Inc. Androstanes and pregnanes for allosteric modulation of gaba receptor
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
AU2012323888A1 (en) 2011-10-14 2014-05-29 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
MX2014008895A (es) 2012-01-23 2014-11-25 Sage Therapeutics Inc Formulaciones de esteroides neuroactivos y metodos para tratar trastornos del cns.
IL294306B2 (en) 2012-08-21 2024-01-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
SI3498725T1 (sl) 2013-04-17 2021-11-30 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituiran C21-N-pirazolilni steroid za uporabo v terapiji
JP6239091B2 (ja) 2013-04-17 2017-11-29 セージ セラピューティクス, インコーポレイテッド 19−ノル神経刺激性ステロイドおよびその使用方法
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3035940B1 (en) 2013-08-23 2018-10-17 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
MX2021004492A (es) 2014-10-16 2022-12-05 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
HRP20201216T1 (hr) 2014-10-16 2020-12-11 Sage Therapeutics, Inc. PRIPRAVCI I POSTUPCI ZA LIJEČENJE POREMEĆAJA CNS-a
JP6893173B2 (ja) 2014-11-27 2021-06-23 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
PL3250210T3 (pl) 2015-01-26 2021-07-26 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
RU2766155C2 (ru) 2016-03-08 2022-02-08 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, их композиции и применения
CA3030420A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
JP7049313B2 (ja) 2016-07-11 2022-04-06 セージ セラピューティクス, インコーポレイテッド C17、c20、およびc21置換神経刺激性ステロイドおよびそれらの使用方法
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
JPS4961150A (xx) 1974-06-13
IE37596B1 (en) 1977-08-31
FR2183792B1 (xx) 1977-07-15
CA1013341A (en) 1977-07-05
SE400771B (sv) 1978-04-10
BE799102A (fr) 1973-11-05
DE2322532A1 (de) 1973-11-22
ES414411A1 (es) 1976-02-01
IL42196A (en) 1978-10-31
CH617710A5 (en) 1980-06-13
GB1430942A (en) 1976-04-07
AU475168B2 (en) 1976-08-12
ZA733035B (en) 1974-04-24
FR2183792A1 (xx) 1973-12-21
IE37596L (en) 1973-11-05
AT355232B (de) 1980-02-25
ATA395173A (de) 1979-07-15
AU5528473A (en) 1974-11-07
IL42196A0 (en) 1973-07-30
LU67546A1 (xx) 1973-07-13

Similar Documents

Publication Publication Date Title
FR2183792B1 (xx)
CS156335B1 (xx)
JPS4960503A (xx)
FR2191804A5 (xx)
JPS5510898B2 (xx)
JPS5324573B2 (xx)
JPS4976407A (xx)
JPS5710657B2 (xx)
JPS4959063A (xx)
JPS4988593A (xx)
JPS4977264A (xx)
JPS4991644U (xx)
JPS4898533U (xx)
JPS4893843U (xx)
CH583251A5 (xx)
CH559080A5 (xx)
CH545876A (xx)
DD99410A1 (xx)
CH585574A5 (xx)
CH583756A5 (xx)
CH583571A5 (xx)
CH583284A5 (xx)
CH585673A5 (xx)
CH582359A5 (xx)
CH581319A5 (xx)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载